An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi, M Sanaei… - International …, 2021 - Elsevier
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
An overview of some potential immunotherapeutic options against COVID-19.
M Bayat, Y Asemani, MR Mohammadi, M Sanaei… - 2021 - cabidigitallibrary.org
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
[HTML][HTML] An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi… - International …, 2021 - ncbi.nlm.nih.gov
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi… - International …, 2021 - eprints.ssu.ac.ir
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
An overview of some potential immunotherapeutic options against COVID-19.
M Bayat, Y Asemani, MR Mohammadi… - International …, 2021 - europepmc.org
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …